VEGFA and neoplasm: However, the localized ischemia and hypoxia brought about during TACE treatment can activate tumorigenic VEGF, IGF-2, and bFGF signaling pathways in some tumors, which can subsequently stimulate angiogenesis and the growth of residual tumor cells, leading to tumor recurrence and metastasis [8, 9].